{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:46:14Z","timestamp":1762865174411},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s00467-006-0230-3","type":"journal-article","created":{"date-parts":[[2006,8,23]],"date-time":"2006-08-23T06:26:48Z","timestamp":1156314408000},"page":"1802-1806","source":"Crossref","is-referenced-by-count":22,"title":["FGF23: its role in renal bone disease"],"prefix":"10.1007","volume":"21","author":[{"given":"Masafumi","family":"Fukagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro James","family":"Kazama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,12,1]]},"reference":[{"issue":"Suppl 2","key":"230_CR1","first-page":"S63","volume":"12","author":"K Kurokawa","year":"1999","unstructured":"Kurokawa K, Fukagawa M (1999) Uremic bone diseases: Advances over the last 30 years. J Nephrol 12 [Suppl 2]:S63\u2013S67","journal-title":"J Nephrol"},{"key":"230_CR2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","volume":"43","author":"WG Goodman","year":"2004","unstructured":"Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N; Vascular calcification work group (2004) Vascular calcification in chronic kidney disease. Am J Kidney Dis 43:572\u2013579","journal-title":"Am J Kidney Dis"},{"key":"230_CR3","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lamiere N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcome (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"230_CR4","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500\u20136505","journal-title":"Proc Natl Acad Sci USA"},{"key":"230_CR5","doi-asserted-by":"crossref","first-page":"F1170","DOI":"10.1152\/ajprenal.00072.2005","volume":"289","author":"TJ Berndt","year":"2005","unstructured":"Berndt TJ, Schiavi S, Kumar R (2005) \u201cPhosphatonins\u201d and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol 289:F1170\u2013F1182","journal-title":"Am J Physiol-Renal Physiol"},{"key":"230_CR6","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1681\/ASN.2005050573","volume":"16","author":"EA Imel","year":"2005","unstructured":"Imel EA, Econs MJ (2005) Fibroblast growth factor 23: Roles in health and disease. J Am Soc Nephrol 16:2565\u20132575","journal-title":"J Am Soc Nephrol"},{"key":"230_CR7","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shimada M, Hasegawa Y, Satoh K, Tajima Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab 87:4957\u20134960","journal-title":"J Clin Endocrinol Metab"},{"key":"230_CR8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of the vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435","journal-title":"J Bone Miner Res"},{"key":"230_CR9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","volume":"314","author":"T Shimada","year":"2004","unstructured":"Shimada T, Urakawa I, Yamazaki Y, Hasegawa H, Hino R, Yoneya T, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2004) FGF-23 transgenic mice demonstrate hypophostemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 314:409\u2013414","journal-title":"Biochem Biophys Res Commun"},{"key":"230_CR10","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","volume":"145","author":"T Larsson","year":"2004","unstructured":"Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Juppner H, Jonsson KB (2004) Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha (I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145:3087\u20133094","journal-title":"Endocrinology"},{"key":"230_CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561\u2013568","journal-title":"J Clin Invest"},{"key":"230_CR12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1744-9987.2005.00292.x","volume":"9","author":"K Miyamoto","year":"2005","unstructured":"Miyamoto K, Ito M, Kuwahata M, Kato S, Segawa H (2005) Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibrous growth factor 23. Ther Apher Dial 9:331\u2013335","journal-title":"Ther Apher Dial"},{"key":"230_CR13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bone.2004.06.014","volume":"35","author":"M Mirams","year":"2004","unstructured":"Mirams M, Robinson BG, Mason RS, Nelson AE (2004) Bone as a source of FGF23: regulation by phosphate? Bone 35:1192\u20131199","journal-title":"Bone"},{"key":"230_CR14","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.lfs.2005.09.052","volume":"78","author":"K Kobayashi","year":"2006","unstructured":"Kobayashi K, Imanishi Y, Koshiyama H, Miyauchi A, Wakasa K, Kawata T, Goto H, Ohashi H, Koyano HM, Mochizuki R, Miki T, Inaba M, Nishizawa Y (2006) Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci 78:2295\u20132301","journal-title":"Life Sci"},{"key":"230_CR15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1744-9987.2005.00293.x","volume":"9","author":"F Koiwa","year":"2005","unstructured":"Koiwa F, Kazama JJ, Tokumoto A, Onoda N, Kato H, Okada T, Nii-Kono T, Fukagawa M, Shigematsu T (2005) Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 level in dialysis patients. Ther Aphr Dial 9:336\u2013339","journal-title":"Ther Aphr Dial"},{"key":"230_CR16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.ki.5000020","volume":"69","author":"N Nagano","year":"2006","unstructured":"Nagano N, Miyata S, Abe M, Kobayashi N, Wakita S, Yamashita T, Wada M (2006) Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int 69:531\u2013537","journal-title":"Kidney Int"},{"key":"230_CR17","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","volume":"146","author":"F Perwad","year":"2005","unstructured":"Perwad F, Azam N, Zhang MYH, Yamashita T, Tenenhouse HS, Portale AA (2005) Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146:5358\u20135364","journal-title":"Endocrinology"},{"key":"230_CR18","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","volume":"64","author":"T Larsson","year":"2003","unstructured":"Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64:2272\u20132279","journal-title":"Kidney Int"},{"key":"230_CR19","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","volume":"90","author":"SL Ferrari","year":"2005","unstructured":"Ferrari SL, Bonjour JP, Rizzoli R (2005) FGF-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519\u20131524","journal-title":"J Clin Endocrinol Metab"},{"key":"230_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.0.1510055","volume":"151","author":"H Yamashita","year":"2004","unstructured":"Yamashita H, Yamashita T, Miyamoto M, Shigematsu T, Kazama JJ, Shimada T, Yamazaki Y, Fukumoto S, Fukagawa M, Noguchi S (2004) Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism. Eur J Endocrinol 151:55\u201360","journal-title":"Eur J Endocrinol"},{"key":"230_CR21","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4065\/79.12.1508","volume":"79","author":"PJ Tebben","year":"2004","unstructured":"Tebben PJ, Singh RJ, Clarke BL, Kumar R (2004) Fibroblast growth factor 23, parathyroid hormone, and 1alpha, 25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism. Mayo Clin Proc 79:1508\u20131513","journal-title":"Mayo Clin Proc"},{"key":"230_CR22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/eje.1.02053","volume":"154","author":"K Kobayashi","year":"2006","unstructured":"Kobayashi K, Imanishi Y, Miyauchi A, Onoda N, Kawata T, Tahara H, Goto H, Miki T, Ishimura E, Sugimoto T, Ishikawa T, Inaba M, Nishizawa Y (2006) Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol 154:93\u201399","journal-title":"Eur J Endocrinol"},{"key":"230_CR23","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","volume":"283","author":"J Silver","year":"2002","unstructured":"Silver J, Kilav R, Naveh-Many T (2002) Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol 283:F367\u2013F376","journal-title":"Am J Physiol Renal Physiol"},{"key":"230_CR24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ki.1972.84","volume":"2","author":"E Slatopolsky","year":"1972","unstructured":"Slatopolsky E, Caglar S, Gradowska L, Canturbury J, Reiss E, Bricker NS (1972) On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using \u201cproportional reduction\u201d of dietary phosphorus intake. Kidney Int 2:147\u2013151","journal-title":"Kidney Int"},{"key":"230_CR25","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","volume":"97","author":"E Slatopolsky","year":"1996","unstructured":"Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ (1996) Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534\u20132540","journal-title":"J Clin Invest"},{"key":"230_CR26","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","volume":"73","author":"AA Portale","year":"1984","unstructured":"Portale AA, Booth BE, Halloran BP, Morris RC Jr (1984) Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 73:1580\u20131589","journal-title":"J Clin Invest"},{"key":"230_CR27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","volume":"18","author":"TJ Weber","year":"2003","unstructured":"Weber TJ, Liu S, Indridason OS, Quarles LD (2003) Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18:1227\u20131234","journal-title":"J Bone Miner Res"},{"key":"230_CR28","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1523-1755.2004.00604.x","volume":"65","author":"Y Imanishi","year":"2004","unstructured":"Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E, Nishizawa Y (2004) FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 65:1046\u20131943","journal-title":"Kidney Int"},{"key":"230_CR29","first-page":"440","volume":"23","author":"N Ito","year":"2005","unstructured":"Ito N, Fukumoto S, Takeuchi Y, Yasuda T, Hasegawa Y, Takemoto F, Tajima T, Dobashi K, Yamazaki Y, Yamashita T, Fujita T (2005) Comparison of two assays for fibroblast growth factor (FGF)-23. J Bone Miner Metab 23:440\u2013453","journal-title":"J Bone Miner Metab"},{"key":"230_CR30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","volume":"44","author":"T Shigematsu","year":"2004","unstructured":"Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F, Fukagawa M (2004) Possible involvement of circulating fibroblast growth factor-23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 44:250\u2013256","journal-title":"Am J Kidney Dis"},{"key":"230_CR31","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205\u20132215","journal-title":"J Am Soc Nephrol"},{"key":"230_CR32","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","volume":"67","author":"S Nakanishi","year":"2005","unstructured":"Nakanishi S, Kazama JJ, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Shigematsu T, Fukagawa M (2005) Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int 67:1171\u20131178","journal-title":"Kidney Int"},{"key":"230_CR33","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00178.x","volume":"67","author":"JJ Kazama","year":"2005","unstructured":"Kazama JJ, Sato F, Omori K, Hama H, Yamamoto S, Maruyama H, Narita I, Gejyo F, Yamashita T, Fukumoto S, Fukagawa M (2005) Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients. Kidney Int 67:1120\u20131125","journal-title":"Kidney Int"},{"key":"230_CR34","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000086347","volume":"101","author":"H Nishi","year":"2005","unstructured":"Nishi H, Nii-Kono T, Nakanishi S, Yamazaki Y, Yamashita T, Fukumoto S, Ikeda K, Fujimori A, Fukagawa M (2005) Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism. Nephron Clin Pract 101: c94\u2013c99","journal-title":"Nephron Clin Pract"},{"key":"230_CR35","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","volume":"280","author":"H Saito","year":"2005","unstructured":"Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N (2005) Circulating FGF-23 is regulated by 1alpha, 25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280:2543\u20132549","journal-title":"J Biol Chem"},{"key":"230_CR36","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","volume":"288","author":"M Ito","year":"2005","unstructured":"Ito M, Sakai Y, Furumoto M, Segawa H, Haito S, Yamanaka S, Nakamura R, Kuwahata M, Miyamoto K (2005) Vitamin D and phosphate regulate fibroblast growth factor-23 in K562 cells. Am J Physiol Endocrinol Metab 288:E110\u2013E1109","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"230_CR37","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1359\/JBMR.050718","volume":"20","author":"MT Collins","year":"2005","unstructured":"Collins MT, Lindsay JR, Jain A, Kelly MH, Cutler CM, Weinstein LS, Liu J, Fedarko NS, Winer KK (2005) Fibroblast growth factor-23 is regulated by 1 alpha, 25-dihydroxyvitamin D. J Bone Miner Res 20:1944\u20131950","journal-title":"J Bone Miner Res"},{"key":"230_CR38","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","volume":"289","author":"OI Kolek","year":"2005","unstructured":"Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, Collins JF, Haussler MR, Ghishan FK (2005) 1 alpha, 25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in the bone: the final link in a renal-gastrointestinal-skeletal axis that control phosphate transport. Am J Physiol Gastrointest Liver Physiol 289: G1036\u2013G1042","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"230_CR39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","volume":"17","author":"S Liu","year":"2006","unstructured":"Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305\u20131315","journal-title":"J Am Soc Nephrol"},{"key":"230_CR40","doi-asserted-by":"crossref","first-page":"64A","DOI":"10.1681\/ASN.2004110969","volume":"16","author":"Y Yamazaki","year":"2005","unstructured":"Yamazaki Y, Urakawa I, Shimada T, Iijima K, Hasegawa H, Fujita T, Fukumoto S, Yamashita T (2005) Identification of essential molecule responsible for tissue specific FGF23 signaling (abstract). J Am Soc Nephrol 16:64A","journal-title":"J Am Soc Nephrol"},{"key":"230_CR41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.mnh.0000168336.67499.c0","volume":"14","author":"GM London","year":"2005","unstructured":"London GM, Marchais SJ, Guerin AP, Metivier F (2005) Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 14:525\u2013531","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"230_CR42","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/ndt\/gfh991","volume":"20","author":"MS Razzaque","year":"2005","unstructured":"Razzaque MS, St-Arnaud R, Taguchi T, Lanske B (2005) FGF-23, vitamin D and calcification: the unholy triad. Nephrol Dial Transplant 20:2032\u20132035","journal-title":"Nephrol Dial Transplant"},{"key":"230_CR43","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1210\/jc.2005-0301","volume":"90","author":"K Araya","year":"2005","unstructured":"Araya K, Fukumoto S, Backenroth R, Takeuchi Y, Nakayama K, Ito N, Yoshii N, Yamazaki Y, Yamashita Y, Silver J, Igarashi T, Fujita T (2005) A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab 90:5523\u20135527","journal-title":"J Clin Endocrinol Metab"},{"key":"230_CR44","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1210\/en.2005-0431","volume":"146","author":"T Larsson","year":"2005","unstructured":"Larsson T, Davis SI, Garringer HJ, Mooney SD, Draman MS, Cullen MJ, White KE (2005) Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed. Endocrinology 146:3883\u20133891","journal-title":"Endocrinology"},{"key":"230_CR45","doi-asserted-by":"crossref","unstructured":"Inaba M, Okuno S, Imanishi Y, Yamada S, Shioi A, Yamakawa T, Ishimura E, Nishizawa Y (2006) Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporosis Int (In press)","DOI":"10.1007\/s00198-006-0154-6"},{"key":"230_CR46","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu M-C, Moe O, Kuro-o M (2006) Regulation of fibroblast growth factor-23 signalling by klotho. J Biol Chem 281:6120\u20136123","journal-title":"J Biol Chem"},{"issue":"7","key":"230_CR47","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/ndt\/gfl178","volume":"21","author":"Ewa Lewin","year":"2006","unstructured":"Lewin E, Olgaard K (2006) Klotho, an important new factor for the activity of Ca2+ channels, connecting calcium homeostasis, ageing and uraemia. Nephrol Dial Transplant. (DOI \nhttps:\/\/doi.org\/10.1093\/ndt\/gfl178\n\n)","journal-title":"Nephrology Dialysis Transplantation"},{"key":"230_CR48","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","volume":"146","author":"X Yu","year":"2005","unstructured":"Yu X, Ibrahimi OA, Goetz R, Zhang F, Davis SI, Garringer HJ, Linhardt RJ, Ornitz DM, Mohammadi M, White KE (2005) Analysis of biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 146:4647\u20134656","journal-title":"Endocrinology"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-006-0230-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-006-0230-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-006-0230-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-006-0230-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T01:36:56Z","timestamp":1574300216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-006-0230-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1007\/s00467-006-0230-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}